 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Aastrom Biosciences, Inc.
 |
Aastrom Biosciences, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
Private capital seen as aid to stem cell research Aug 14 2001 03:18 PM PDT
Stem cell stocks give back gains after Bush speech Aug 10 2001 09:27 AM PDT
Eurostocks weak, D.Telekom sinks, Aegon gains Aug 10 2001 07:22 AM PDT
Hot stocks highlights -- Aug. 10 Aug 10 2001 07:15 AM PDT
Before the Bell - Futures lower, StemCells off, Philip Morris up Aug 10 2001 06:27 AM PDT
> More WIRE STORIES about this company
PROFILE |
 |
Development-stage Aastrom Biosciences offers hope to cancer patients. Its AastromReplicell equipment grows bone marrow cells and umbilical cord cells (less controversial sources for stem cells than embryonic cells) used to replace cells damaged by cancer treatments. The system is designed to be less costly, faster, and less invasive than such traditional cell-replacement methods as blood transfusion and bone marrow harvesting. AastromReplicell is being sold in Europe and has been approved in the US for research and investigational use. The company is also developing the Aastrom Gene Loader, through which therapeutic genes can be transferred into target cells.
COMPETITION |
 |
CRYO-CELL International, Inc. (CCEL)
Celox Laboratories, Inc. (CELX)
Nexell Therapeutics Inc. (NEXL)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: June
2000 Sales (mil.): 1.20
1-Yr. Sales Growth: 33.3%
Employees: 30
Revenue per employee: $40,000.00
KEY PEOPLE |
 |
R. Douglas Armstrong
CEO
Todd E. Simpson
CFO
CONTACT INFO |
 |
24 Frank Lloyd Wright Dr.
Ann Arbor, MI 48105
US
Phone: 734-930-5777
Fax: 734-930-5546
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |